Provided by Tiger Fintech (Singapore) Pte. Ltd.

SpringWorks Therapeutics, Inc.

41.33
+0.83002.05%
Volume:1.17M
Turnover:48.02M
Market Cap:3.10B
PE:-11.87
High:42.15
Open:41.83
Low:40.37
Close:40.50
Loading ...

SpringWorks EU approval would enhance strategic value, says Evercore

TIPRANKS
·
22 Apr

Positive opinion for Ogsiveo would de-risk SpringWorks deal, says Barclays

TIPRANKS
·
22 Apr

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
19 Apr

BofA Adjusts Price Target on Springworks Therapeutics to $84 From $87, Keeps Buy Rating

MT Newswires Live
·
17 Apr

SpringWorks Therapeutics Inc : Bofa Global Research Cuts Price Objective to $84 From $87

THOMSON REUTERS
·
17 Apr

Springworks Therapeutics (SWTX) Receives a Buy from Bank of America Securities

TIPRANKS
·
17 Apr

Here's Why We're Not At All Concerned With SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation

Simply Wall St.
·
13 Apr

Top Stock Reports for Mastercard, Medtronic & HCA Healthcare

Zacks
·
01 Apr

Biotech stocks have been hit by 'DOGE' and other fears. Why they're a great value now.

Dow Jones
·
27 Mar

BRIEF-Merck KGaA CEO: Impact From U.S. Tariffs On China Will Be Manageable

Reuters
·
06 Mar

Merck KGaA CEO Says We Refer to Our Previous Statement on SpringWorks, When Asked About Any Progress of Talks

THOMSON REUTERS
·
06 Mar

Investors push SpringWorks Therapeutics (NASDAQ:SWTX) 4.9% lower this week, company's increasing losses might be to blame

Simply Wall St.
·
06 Mar

Is SpringWorks Therapeutics, Inc. (SWTX) The Best Immunology Stock To Buy Now?

Insider Monkey
·
02 Mar

J.P. Morgan Sticks to Its Buy Rating for Springworks Therapeutics (SWTX)

TIPRANKS
·
25 Feb

SpringWorks Therapeutics Price Target Maintained With a $74.00/Share by HC Wainwright & Co.

Dow Jones
·
22 Feb

BUZZ-SpringWorks Therapeutics rises as canceled earnings call raises buyout hopes

Reuters
·
20 Feb

Springworks Therapeutics Q4 Net Loss Narrows

MT Newswires Live
·
20 Feb

Stock Track | SpringWorks Therapeutics Soars 14.88% in Pre-market on Strong Q4 Revenue, FDA Approval for New Drug

Stock Track
·
20 Feb

Earnings Flash (SWTX) Springworks Therapeutics Posts Q4 Net Loss $-1.04 a Share, vs. FactSet Est of $-0.71 Loss

MT Newswires Live
·
20 Feb

SpringWorks Therapeutics FY 2024 GAAP EPS $(3.48) Misses $(3.06) Estimate, Sales $191.59M Beat $190.92M Estimate

Benzinga
·
20 Feb